Trademark: 97340109
Word
CORRIXR THERAPEUTICS
Status Date
Tuesday, October 10, 2023
Filing Date
Thursday, March 31, 2022
Published for Opposition
Tuesday, August 15, 2023
42 Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development; research and development of therapeutics pharmaceuticals using gene editing; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy
Apr 11, 2024
Case Assigned To Intent To Use Paralegal
Apr 2, 2024
Sou Teas Extension Received
Oct 10, 2023
Noa E-Mailed - Sou Required From Applicant
Aug 15, 2023
Official Gazette Publication Confirmation E-Mailed
Aug 15, 2023
Published For Opposition
Jul 26, 2023
Notification Of Notice Of Publication E-Mailed
Jul 10, 2023
Approved For Pub - Principal Register
Jul 7, 2023
Teas/Email Correspondence Entered
Jul 7, 2023
Correspondence Received In Law Office
Jul 7, 2023
Teas Response To Office Action Received
Apr 20, 2023
Notification Of Non-Final Action E-Mailed
Apr 20, 2023
Non-Final Action E-Mailed
Apr 20, 2023
Non-Final Action Written
Apr 20, 2023
Previous Allowance Count Withdrawn
Apr 18, 2023
Withdrawn From Pub - Og Review Query
Apr 4, 2023
Approved For Pub - Principal Register
Apr 3, 2023
Teas/Email Correspondence Entered
Apr 3, 2023
Correspondence Received In Law Office
Apr 3, 2023
Teas Response To Office Action Received
Jan 18, 2023
Notification Of Non-Final Action E-Mailed
Jan 18, 2023
Non-Final Action E-Mailed
Jan 18, 2023
Non-Final Action Written
Jan 18, 2023
Assigned To Examiner
Apr 5, 2022
New Application Office Supplied Data Entered
Apr 4, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
